FDA – SoCal IP Law Institute

SoCalIP Law Institute Weekly Meeting – March 6, 2023 – Rx patent monopoly and Lizzo TM win

Please join us Monday, March 6, 2023 where we will discuss Rx patent monopoly issues and Lizzo's TM win. Specific case discussions will include: AbbVie Rx Patent Monopoly Strategy Against Biosimilars - AbbVie makes Humera for arthritis and extended its monopoly for 7 years past the 2016 expiration date of its basic patent on the [...]

By Guy Cumberbatch|2023-03-02T12:51:55-08:00March 2nd, 2023|Antitrust, FDA, Patent, Trademark, TTAB, monopoly|0 Comments

SoCal IP Institute :: November 28, 2013 :: How FDA Legal Issues Shape Human Health

Our weekly SoCal IP Institute meeting on Monday, November 28, 2013 included a discussion by Michael H. Cohen of the Michael H. Cohen Law Group regarding the ways in which FDA legal issues shape human health. A copy of Mr. Cohen's PowerPoint slides from that discussion is available here.

By SoCal IP|2013-12-11T01:11:27-08:00December 11th, 2013|FDA|0 Comments